In this episode, Dr. Stephen Byrn, Head of Aptuit Scientific Advisory Board, speaks about the critical path problem in drug development and how a designed molecular delivery system can improve the drug development process.

Issues and Innovations in Drug Development presented by Aptuit

Molecular Design and the Critical Path Problem

In this episode, Bob Burford Ph.D., Managing Director, Aptuit Consulting discusses the relationship between drug developers and CROs, including current market conditions, the changing needs of drug developers, how to choose an outsourcing provider, expectations of a CRO, and the future of this important relationship.

Redefining the CRO

In this installment of the series, Doug Meyer, Senior Director for Aptuit Informatics, discusses the role and importance of informatics in today’s clinical trial environment.

Informatics and clinical supply chain management: A stronger link for the drug development

Thank you for subscribing to our podcast series. Aptuit will continually update the series with interviews from experts across the entire drug development continuum.

hubhopper

Issues and Innovations in Drug Development presented by Aptu...

hubhopper